Tyrosine kinase inhibitors targeting vascular endothelial growth factor and the risk of aortic dissection-A pharmacovigilance analysis

• Príomhchruthaitheoirí: Michael Dörks (Údar), Kathrin Jobski (Údar), Stefan Herget‐Rosenthal (Údar), Falk Hoffmann (Údar), Antonios Douros (Údar)
• Formáid: LEABHAR
• Foilsithe / Cruthaithe: Wiley, 2021-02-01T00:00:00Z.
• Ábhair: article
• Rochtain ar líne: Connect to this object online.

Abstract There are concerns by the United States Food and Drug Administration (FDA) regarding a potential link between tyrosine kinase inhibitors targeting vascular endothelial growth factor (VEGF‐TKIs) and the risk of aortic dissection. Elevation of blood pressure induced by VEGF‐TKIs has been disc...